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Abstract
Background: Juvenile Idiopathic Arthritis (JIA) is the most common cause of non-infectious joint inflammation in
children. Synovial inflammation results in pain, swelling and stiffness. Animal and adult human studies indicate that
localized joint-associated inflammation may produce generalized changes in pain sensitivity. The aim was to
characterize pain sensitivity in children with JIA to mechanical and thermal stimulus modalities using quantitative sensory
testing (QST) at an affected inflamed joint, and compare to children in clinical remission. Generalized hypersensitivity was
evaluated by comparing QST measures at the thenar eminence between JIA and healthy control children.
Methods: 60 children aged 7–17 years with JIA participated. QST assessed sensory detection threshold and pain
threshold at two sites: (1) affected joint (clinically active or inactive), (2) contralateral thenar eminence. Joint site included
finger, wrist, knee and ankle. Clinical status was measured using objective and subjective markers of disease severity.
Questionnaires assessed pain intensity and frequency, functional disability, anxiety, pain catastrophization and fatigue.
QST data collected from joints were compared within JIA patients: active vs. inactive inflammation; and data from the
contralateral thenar eminence were compared between JIA and healthy control cohorts in Europe [EU, (n=151)] and
the US (n= 92). Statistical analyses were performed using Kruskal-Wallis with Dunn’s post-hoc comparison, Mann-Whitney
or Fisher’s exact test, where appropriate.
Results: Overall, children with JIA reported low pain scores and low degrees of functional disability. Sensory detection
thresholds and pain thresholds were similar in “active” compared to “inactive” joints. Despite this, children with JIA had
generalized hypersensitivity at the thenar eminence when compared to healthy children for pressure (vs. EU p< 0.001),
light touch (vs. EU p< 0.001), cold (vs EU, p< 0.01; vs US, p< 0.001) and heat pain (vs EU, p< 0.05; vs US p<0.001).
Conclusions: JIA is associated with increased sensitivity to painful mechanical and thermal stimuli, even in absence of
pain reports, or markers of disease activity. Future research investigating mechanisms underlying pain hypersensitivity in
JIA is warranted; this will in turn guide pharmacologic and non-pharmacologic interventions to prevent or reverse these
processes.
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Juvenile Idiopathic Arthritis (JIA) is the most common
chronic rheumatologic disease in children. It is character-
ized by synovial inflammation, resulting in pain, swelling,
and stiffness [1,2]. Pain has a considerable effect on the
child’s well-being and is associated with sleep disturbances,
functional disability, and psychosocial distress [3]. In some
children with JIA whose disease is well-controlled with
anti-inflammatory therapy and who have no clinical signs
of joint inflammation, pain continues to be a burden [4].
Prolonged pain could be due to ongoing inflammation, or
may reflect long-term changes in underlying central
and peripheral sensory processing mechanisms during
an important time of development in childhood [3].
Previous studies of sensory function in children with JIA
have largely concerned pressure pain perception. Children
with chronic inflammatory arthritis show widespread
reductions in pressure pain threshold [5-7]. Even in the
absence of clinical signs of joint inflammation, children
with JIA who are in remission show pressure pain hyper-
sensitivity compared to healthy controls, and this extends
to non-joint areas not associated with JIA [5].
Quantitative sensory testing (QST) is a non-invasive
approach used in pain research to assess large and small
nerve fiber function. It is useful for assessing nociceptive
(small fiber Aδ, C) and non-nociceptive (large Aβ) mech-
anical sensations [8]. Thermal, mechanical touch and
vibration detection thresholds, as well as cold, heat, deep
pressure and mechanical pain can be assessed at multiple
sites across the body. QST has been used extensively in
adults, and in children, using a modified protocol that is
feasible in children from 5 years of age [9-11].
Previous studies provide evidence to suggest that pressure
pain hypersensitivity exists in areas unaffected by inflamma-
tion, and also in children with JIA in clinical remission
[5-7]. However, there is little information regarding the
complete mechanical and thermal sensory profile of
children with JIA. The primary aim of this study was to
examine sensory detection threshold and pain threshold
in children with JIA at the site of active inflammation, at
the upper extremities: fingers (distal or proximal interpha-
langeal joint) or wrist; or lower extremities: knee or ankle,
and compare to children in clinical remission. Sensory
thresholds at the contralateral thenar eminence (a remote,
non-joint control site) were then compared against
two sets of healthy age-matched controls cohorts from the
US and Europe.
Methods
Study design
JIA patients were recruited from the Rheumatology Clinic
at Boston Children’s Hospital during routine clinic visits
from November 2012 to September 2013. Subjects
underwent quantitative sensory testing (QST) at a joint
and non-joint control (thenar eminence) site (see Methods-
QST), after completing a series of psychological question-
naires on the day of their visit. Demographics and clinical
information including age, gender, disease duration, JIA
subtype and markers of disease activity were collected by
the treating rheumatologist ont h ed a yo ft h es t u d yv i s i t .
Children and adolescents were eligible if they were
aged 7 to 17 years and diagnosed with JIA. Additional
criteria were (1) English speaking; (2) absence of cognitive
impairment or a known developmental disability; and (3)
no evidence of a neurological disorder. Use of analgesics
or non-steroidal anti-inflammatory drugs (NSAID) on the
day of testing were noted for all children. No patients were
taking opioid analgesia at the time of study.
Parents/guardians provided written informed consent
and all patients provided written assent. The Institutional
Review Board at Boston Children’s Hospital approved the
study.
Markers of disease activity and duration
Measurements for classifying the subject’s disease activity
level according to the Juvenile Arthritis Disease Activity
Score (JADAS-10) criteria were collected by the examining
pediatric rheumatologist at each study visit [12,13].
Parameters followed included (1) number of joints with
active arthritis; (2) physician global assessment of disease
activity, measured on a 10 cm visual analog scale (VAS)
where 0= no activity and 10= maximum activity; (3)
parent/patient assessment of overall well-being, mea-
sured on a 10 cm VAS scale where 0 =very well and
10=poor; (4) functional ability (Child Health Assessment
Questionnaire, C-HAQ); (5) measures of systemic inflam-
mation (Erythrocyte Sedimentation Rate or C-reactive
protein level).
Pain experience, functional status and psychosocial
factors
Pain experience (pain intensity and frequency), functional
disability and mental health status were assessed using a
series of self-report written questionnaires completed by
subjects before performing QST.
Pain intensity on the day of study was rated on a
standard numerical rating scale of 0–10, where 10 is
worst pain imaginable. Frequency of pain episodes over
the last year was evaluated with the following question:
“Please put a circle that best describes how often you
feel pain: (a) never in the past year, (b) about once a year,
(c) several times a year, (d) once a month, (e) several times
at month, (f) about once a week, (g) several times a week,
(h) daily or almost daily”.
Functional disability was measured using the Functional
Disability Inventory (FDI). The FDI is used to assess
the extent of pain-related functional impairment across
domains (e.g. physical and social functioning) and is a
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was measured using the child version of the Pain
Catastrophizing Scale (PCS) [17,18]. Presence of psycho-
social dysfunction of daily life at home, school, with
friends, in activities, and/or in mood or self-esteem was
assessed using the Pediatric Symptoms Checklist [19,20].
Trait anxiety was assessed with “trait” portion of the
State Trait Anxiety Inventory for Children (T-STAIC)
[21]. Pediatric rheumatology-specific quality of life for
fatigue was assessed using the PedsQL Multidimen-
sional Fatigue Scale (PedsQL), a validated and reliable
instrument designed to measure general, sleep/rest
and cognitive fatigue [22].
Quantitative Sensory Test (QST)
Test site
QST was performed at two sites on the body: (1) an
affected joint and (2) the contralateral thenar eminence.
Signs of joint inflammation were identified by individual as-
sessment from the physical examination. The “Active” joint
was identified as the joint with the most significant inflam-
mation, swelling or tenderness. For those patients who did
not have an “Active” joint, an “Inactive” joint, with
the most inflammation in the past was tested (as re-
ported in the medical notes or by the patient). Joint
test site was the distal or proximal interphalangeal
joint, wrist, knee or ankle. The contralateral thenar
eminence was the control site.
Protocol
The QST protocol consisted of a series of 8 sensory tests.
Mechanical (MDT), vibration (VDT), cool (CDT) and
warm (WDT) detection thresholds, mechanical “punctate”
pain (MPT), pressure pain (PPT), cold pain (CPT) and
heat pain thresholds (HPT) were assessed. We used a
modified QST protocol that has been validated in healthy
children and adolescents previously by our group [11,23].
We included additional sensory tests designed to assess
mechanical tactile and pressure stimulus modalities; these
modalities were tested according to the recommendations
published by our collaborators in Germany [9]. All thresh-
olds were determined using the Method of Limits ap-
proach that uses stimuli of increasing intensity, starting at
sub-threshold levels, to determine sensory thresholds [11].
A copy of the QST script used is available in the
Additional file 1. The QST protocol was performed in the
order listed below:
Mechanical stimuli: Mechanical detection (MDT) and
Mechanical pain threshold (MPT) A standardized set
of Von Frey hairs (North Coast Medical, USA) that exert
precise forces between 0.008 g and 300 g were applied
perpendicularly to the skin, and the subject asked to
report the sensation felt, if any. Children were asked
to report when they first felt a sensation for MDT
(this was repeated 3 times), and when they felt a
sharp-prick like sensation for MPT (repeated 2 times
at each site). Stimuli were applied at slightly different
sites within a small area to avoid habituation.
Vibration detection threshold (VDT) A vibrometer
consisting of a small computer-controlled round plastic
disc (1 cm
2) was placed perpendicularly to the test site
and the frequency of vibration was gradually increased
in strength until the patient felt sensation (TSA II,
Medoc Inc., Israel). The patient was asked to press a
button when the vibration sensation was first felt. This
test was repeated 8 times.
Pressure pain threshold (PPT) A pressure algometer
(FDX 50,Wagner Inc., USA) was used to quantify pres-
sure sensation. A small flat disc with a surface area of
1.1 cm
2 attached to a hand-held probe was held perpen-
dicularly to the test site and gradually brought in contact
with the skin. The patient was asked to report when
s/he felt pressure pain (PPT). This was repeated 3
times.
Thermal stimuli: Cool and warm detection (CDT,
WDT), cold and hot pain threshold (CPT, HPT) A
computer-operated thermodew a sp l a c e do nt h es k i na n d
secured by a Velcro strap (TSA II, Medoc Inc., Israel). The
thermode contact area measured 1.6 × 1.6 cm. The baseline
temperature was 32°C and cut-off temperature limits were
0 and 50°C. For cool and warm detection assessment, the
rate of temperature change was 1°C/s; for cold and heat
pain threshold assessment, the rate of temperature change
was 1.5°C/s. The patient was asked to identify the sensa-
tions of warmth and cool, and hot and cold by pressing a
button when each sensation was first felt. Once the button
was pressed, the value was automatically recorded and the
thermode temperature returned to baseline at rate of 1°C/s
for cool and warm sensation, and 10°C/s for cold and hot
pain. Cool and warm stimuli were measured 4 times, and,
hot and cold stimuli 3 times.
Study visit information
Studies were conducted in the clinic room by a trained
sensory physiologist on the day of the clinic visit. Patients
were given time to adapt to the room temperature, be
introduced to the questionnaires and QST equipment.
Patients were seated on the clinic bed, positioned such
that they could not see what was appearing on any data
collection monitors, and during testing were asked to keep
their eyes closed. Parent(s) or guardians were present
throughout the testing.
Each study visit took an average of 40.5 min (SD=
10.1 min) to complete. We were able to maintain the
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temperature was 24.7°C (SD=2.2) and mean room
humidity was 45.1% (SD=15.7). All subjects detected
mechanical pain at a higher force than mechanical detec-
tion, cold pain at a lower temperature than cool detection
threshold, and hot pain at a higher temperature than
warm sensation threshold. These data provide a control
that the youngest children understood the verbal instruc-
tions. No subject withdrew from the protocol.
Control groups
Previous data collected from QST studies in healthy
children and adolescents were used as control groups
[9,11]. Results of QST can be influenced by the
subtleties of testing protocols and testing situation. In
order to make comparisons more generalizable and to
account for some improvements in testing paradigms
over time, we chose prospectively to include two large
cohort QST data sets acquired from healthy children
i nt h eU Sa n dG e r m a n y( E u r o p e ,E U )[ 9 , 1 1 ] .
For the US controls, 5 QST parameters were evaluated at
the thenar eminence and the foot in 101 subjects aged 6–17
years: vibration detection threshold (VDT), and thermal
thresholds [cold detection, (CDT), warm detection (WDT),
cold pain (CPT) and heat pain (HPT)]. Vibratory and
thermal thresholds were evaluated using an automated
vibrometer and 3×3 cm Peltier thermode (TSA II,
Medoc Inc., Israel). Subjects were recruited from the
hospital staffs’ children, the well-child outpatient clinic and
from a local school. Healthy children with no evidence of
neurological disorders were eligible for the study. Children
younger than 7 years were excluded from our analysis. The
final US control group included QST data from 92 of the
total 101 children.
European controls were tested for 13 QST parameters
from the thenar eminence, masseter and ball of the foot. A
total of 167 subjects aged 6–16 years were recruited from
two primary and secondary schools. QST parameters used
for comparison in the present study include mechanical
detection threshold (MDT), pressure pain threshold (PPT),
and thermal threshold (CDT, WDT, CPT and HPT). MDT
was evaluated using von Frey hair filaments (Optihar1-Set,
Marstock Nervtest, Germany), PPT with a 1.1 cm
2 tip
algometer (FDX100, Wagner Instruments, USA), and
thermal thresholds with a 3×3 cm Peltier thermode (TSA
II, Medoc Inc., Israel). Children younger than 7 years were
excluded from our analysis. The final European control
group included QST data from 151 of the 167 children.
Statistical analysis
Sample size calculation
The primary outcome measures were sensory threshold
in JIA “Active” and “Inactive” joint groups. Availability
of QST reference data available for the small joints in
the pediatric population is limited. We used pressure
pain threshold (PPT) as the representative measure of QST
because this parameter shows consistent somatosensory
abnormalities in children with chronic arthritis.
Previous studies reported JIA patients have a mean
PPT of 14 N lower than healthy controls across multiple
sites [5]. Mean PPT (47.6 N) and SD (17.5 N) values
from the thenar eminence of EU healthy controls were
taken as the reference normal. To find a mean difference of
14 N between JIA patients with active and with inactive
arthritis, 52 patients (26 per group) were required to achieve
ap o w e ro f8 0 %( ‘moderate’ effect size: 14/17.5=0.8; two-
tailed α=0 .05 ; β =0.2); (nQuery v7, Statistical Solutions,
MA). We enrolled patients using a convenience sample
approach. Therefore, the finals a m p l es i z eo f6 0J I Ap a t i e n t s
in the cohort provided sufficient statistical power for
capturing differences that we considered significant
between JIA patients with active and inactive arthritis.
Secondary measures were sensory threshold changes
between all JIA patients and healthy control groups,
and QST predictors (see Methods- Statistics).
Statistics
Median, interquartile range (IQR), mean, standard deviation
(SD), are given as appropriate. Thermal threshold values
( C D T ,W D T ,C P T ,H P T )a r eg i v e na sc h a n g ef r o mb a s e l i n e
thermode temperature of 32°C, and absolute values where
indicated. All data were tested for normality using the
D'Agostino & Pearson omnibus test and followed a non-
parametric distribution. For QST, we were unable to collect
data in some children with JIA for vibration (n=7), thermal
(n=4) and pressure (n=2) stimulus modalities due to
technical issues; we did not substitute missing data.
Psychological questionnaires were excluded from the
final analysis if a child did not complete more than
85% questions. For partially completed psychological
questionnaires, the mean score for the individual was
used as a substitute value for unanswered questions.
All statistical analyses were performed with GraphPad
Prism 5.04 (GraphPad Software, Inc, USA) and STATA
(StataCorp LP, USA).
Comparison within JIA patients JIA patients were
divided into two cohorts according to the location of the
joint tested: (1) upper extremities (distal or interphangeal
joint, or wrist); or (2) lower extremities (knee or ankle).
Each cohort was subdivided into two groups depending
on the clinical inflammatory status of the joint evaluated:
“Active” or “Inactive” joint. Within-cohort comparisons
were performed to evaluate differences sensory detection
and pain thresholds at the joint test-site. All four JIA
groups (inclusive of location of test joint and inflam-
matory status) were compared to evaluate differences in
sensory detection and pain thresholds at the control site.
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Dunn’s correction, or Fisher’s exact test, where appropriate.
QST predictors Multiple linear regression analyses of
the evaluated joint were applied for each QST measure.
We aimed to evaluate the association of demographic
variables and other clinical factors, besides the inflam-
matory state of the joint, on QST threshold. We created
a general model for each QST parameter that included
potential variables associated with the change in sensory
thresholds and pain [24]. The explanatory variables
included in the model were test site, age, gender,
markers of disease activity, and psychological question-
naire scores. Results are expressed as R2 of the model,
the adjusted β coefficient in each predictor value, and
significance level. To correct for multiple comparisons,
two-tailed p< 0.01 with Bonferroni correction were
considered significant.
Comparison between JIA and controls For comparison
of sensory detection thresholds and pain thresholds in
JIA patients versus healthy controls, QST data were
taken from the thenar eminence. Each QST parameter
tested in the JIA group was compared to the available QST
parameter of each separate control group. Mann–Whitney
testing was used for these comparisons, assuming signifi-
cance level less than 0.05..
Results
Subjects
JIA patients
Demographics and clinical characterization of the JIA
patients are shown in Table 1. A total of 60 JIA patients,
44 girls and 16 boys (median, 13.0 years; IQR: 9.6-15.5)
participated in this study. There was no difference in age
between girls and boys (p=0.76). The main JIA subtypes
were polyarticular (48%) and psoriatic (22%). Sixty-eight
percent of children enrolled into the study were taking
disease-modifying agents at the time of testing (41/60).
Methotrexate was most commonly taken (55% total
subjects), followed by etanercept (27%), infliximab (10%),
lefluomide (3%) and sulfasalazine (1.6%); Table 1. Eight
children were taking daily NSAIDs at the time of study
(2 with active arthritis, and 6 in clinical remission).
Age, gender and duration ofr h e u m a t o l o g yc l i n i c
attendance were comparable between the “Active” joint
and “Inactive” joint JIA groups (Table 1). Overall, markers
of disease activity were low across the JIA patients.
Table 1 Age, gender and clinical characteristics of children with JIA
a
JIA patients
QST joint status
Characteristics Total (n=60) Active (n=23) Inactive (n= 37) p-value
b
Female patients, n (%) 44 (73%) 17 (74%) 27 (73%) 0.94
c
Age at study visit, years 13.0 (9.6-15.5) 10.6 (9.4-15.0) 14.4 (9.7-15.9) 0.22
Duration of rheumatology clinic attendance, years, mean (SD) 5.8 (3.9) 4.9 (4.0) 6.4 (3.8) 0.17
d
Markers of disease activity
Physician's global assessment of overall disease activity
e 1.0 (0.0-2.0) 2.0 (1.0-3.0) 0.7 (0.0-1.1) <0.01
No. of active joints 1.0 (0.0-3.0) 3.0 (2.0-9.0) 0.0 (0.0-0.5) <0.001
Patient's pain assessment
f 0.0 (0.0-2.0) 2.0 (0.0-3.5) 0.0 (0.0-2.0) 0.21
Patient's global assessment of overall wellbeing
g 1.0 (0.0-2.7) 1.2 (0.6-2.8) 0.0 (0.0-2.9) 0.10
C-HAQ score
h 0.0 (0.0-0.13) 0.0 (0.0-0.25) 0.0 (0.0-0.0) 0.13
Erythrocyte sedimentation rate, mm/hour
i 8.0 (4.0-11.0) 8.5 (5.0-12.5) 8.0 (3.0-11.0) 0.37
C-reactive protein level, mg/L
j 0.1 (0.04-0.2) 0.1 (0.07-0.26) 0.1 (0.04-0.2) 0.77
Medications (n)
Methotrexate 33 (55%) 14 19
Etanercept 16 (27%) 6 10
Infliximab 6 (10%) 1 5
Leflunomide 2 (3%) 0 2
Sulfasalazine 1 (1.6%) 0 1
C-HAQ: Child Health Assessment Questionnaire; IQR- Inter-Quartile Range; QST- Quantitative Sensory Testing; SD, Standard deviation.
a.All values given as median (IQR) unless otherwise stated.
b.p-values indicate differences in JIA patients with active compared to clinically inactive joints.
Mann–Whitney test used unless otherwise stated. Boldface highlights significant differences.
c.Fisher’s Exact test.
d.Unpaired Student’s t-test.
e.Data available for
29 patients (Active, n = 7; Inactive, n = 22).
f.Data available for 55 patients (Active, n = 21; Inactive, n= 34).
g.Measured on a 100 mm visual analogue scale
(0, best; 10, worst). Data available for 43 patients: Active, n= 17; Inactive, n = 26)
h.Data available for 45 patients (Active, n = 17; Inactive, n= 28).
i.Data available for
51 patients (Active, n = 20; Inactive, n = 31).
j.Data available for 53 patients (Active, n = 21; Inactive, n = 32).
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were significantly different between subgroups (p<0.01
and p<0.001 respectively; Table 1).
Pain scores were low across the entire JIA sample. The
“Active” joint group showed a trend towards higher pain
scores, rating in the mild intensity range (2.0, IQR: 0.0-3.5);
this was not significantly different to the “Inactive” group
(vs. 0.0, IQR: 0.0-2.0; p=0.10). Subjects in the “Active” joint
group experienced more frequent pain episodes, where
67% of subjects reported pain occurring at least once a
week, compared to only 32% in the “Inactive” joint group
(Fisher’se x a c tt e s t ,p=0 . 0 2 ) .
Fifty-four patients completed all 5 questionnaires
(4 children did not complete any questionnaires, 1
child completed 3/5, and 1 child completed 4/5).
Collectively, scores for functional and psychological
measures for JIA patients were within normative
ranges. Functional disability (FDI) scores were rated in the
lowest quartile, indicating no or minimal levels of overall
disability (median score 1.0; IQR: 0.0-7.0). Trait anxiety
and pain catastrophizing were evaluated with the T-STAIC
and PCS questionnaires, with median scores of 26.0
(IQR: 22–33) out of 60, and 8 (IQR: 3–16) out of 64
respectively. Pediatric Symptoms Checklist scores
were 9.5 (IQR 3.0-15.0) out of 70, with a score >28
being the cut-off for psychological impairment. In
PedsQL fatigue assessment a high score indicates little
impairment of quality of life due to fatigue. In the
study sample, median PedsQL score was 88.0% (IQR:
66.0-96.0) which reflects little impact of fatigue on
quality of life [22]. One child with JIA scored 11% on the
PedsQL fatigue assessment, and this child had high scores
in measures of functional disability (FDI: 21/60) and
moderate scores in trait anxiety (T-STAIC: 31/60), pain
catastrophizing scale (PCS: 13/64), pediatric symptoms
checklist (PSC: 23/70), but was not an outlier in any of the
pain perception or sensory threshold QST measurements.
Healthy controls
D e t a i l so ft h ec o n t r o lg r o u p sa r ed e s c r i b e di nt h eM e t h o d s .
Ages of children with JIA were comparable to healthy US
controls (US controls: 13.0 years, IQR: 10.0-13.8; p = 0.26).
T h e r ew a sad i f f e r e n c ei na g eb e t w e e nc h i l d r e nw i t hJ I A
and healthy EU controls, but the median values lay in close
range (EU controls: 11.0 years, IQR: 9.0-14.0; p< 0.05). For
both the healthy US and EU controls, 50% of subjects were
female, and in the JIA cohort this was 73% female.
Comparison of sensory detection threshold and pain
threshold with joint inflammation status
Table 2 summarizes the sensory detection threshold and
pain threshold data at the joint test-site in children
with JIA according to inflammation status of the joint
(i.e. “Active” or ““Inactive”) and location of QST testing
site (i.e. upper or lower extremity). All 60 JIA patients
enrolled into the study completed MDT and MPT tests;
we have missing values for PPT (n=2), VDT (n=7) and
thermal tests (n=4) due to technical failure.
Pain threshold
No significant group differences were found at the
“Active” joint and the “Inactive” joint for pressure pain
threshold (upper extremity, p= 0.27; lower extremity,
p=0.85), or for mechanical pain threshold (upper
extremity, p=0.17; lower extremity, p=0.40). Thermal
sensitivity was not different for cold pain threshold
(upper extremity, p=0.06; lower extremity, p=0.87), or
heat pain threshold (upper extremity, p=0.62; lower
extremity, p=0.19) for “Active” or “Inactive” joints.
Sensory detection threshold
No significant group differences were observed at the
“Active” joint group and the “Inactive” joint group
for mechanical detection threshold (upper extremity,
p=0 .1 1 ; l ower ex tr emi ty, p=0 . 26 ) , or for vib rati on
detection thresholds (upper extremity, p=0.87; lower
extremity, p=0.21). Cool detection threshold, or warm
detection threshold also did not differ between joints with
active or inactive inflammation (CDT: upper extremity,
p=0.83; lower extremity, p=0.78; WDT: upper extremity,
p=0.64; lower extremity, p=0.87).
Control site (thenar eminence) sensitivity
There were no significant differences in seven out of 8
sensory detection or pain threshold parameters (Table 3).
Notably, cold pain was the most variable measure, and
was shown to be significantly different among JIA
groups (p= 0.03). Specifically, significant differences for
CPT found between JIA patients with active arthritis
in the upper extremity vs lower extremity after Dunn’s
correction [active upper: 29.1°C (25.0-30.6); active lower:
21.1°C (15.5-25.4)].
QST predictors for children with JIA
We employed linear multiple regression analyses to
evaluate whether demographic or clinical factors were
associated with QST sensory detection thresholds or pain
thresholds at the joint test-site.
Site-specific differences were found (upper extremity
vs. lower extremity) for heat pain, thermal cool and
warm detection, and vibration detection. Compared to
the lower extremities, the upper extremities had lower
sensory thresholds (increased sensitivity) to heat pain
(HPT: β=0.09, p=0.028), thermal detection threshold
(CDT: β=0.23, p<0.001; WDT: β= 0.17, p= 0.002) and
vibration detection threshold (VDT: β =0.35, p <0.001).
For the other QST parameters there were no other
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regression analysis included joint site tested in the models.
Hypersensitivity to thermal and mechanical stimuli
was not associated with laboratory markers of disease
activity (Erythrocyte Sedimentation Rate, C-reactive
protein), CHAQ scores and duration of treatment for
JIA (see Additional file 2: Table A).
Significant positive associations were found for the
following QST variables: (1) Mechanical pain hypersensitiv-
ity (lower pain thresholds) with higher trait-anxiety scores
(T-STAIC) (β=0.12, p = 0.013); (2) cold pain hypersensitiv-
ity with females (β =0.22, p< 0.001); and (3) cool de-
tection hypersensitivity with higher PedsQL fatigue scores
(β= 0.32, p= 0.012).
Comparison of sensory detection threshold and pain
threshold between children with JIA and healthy controls
We evaluated sensory detection and pain thresholds in
children with JIA at the thenar eminence, and compared
to healthy control dataset(s). There was no visible local
inflammation at the thenar eminence in any child with
JIA. Data from the children with JIA were pooled.
Pain threshold
Figure 1 illustrates the differences in pain threshold
between JIA patients and healthy controls for pressure and
thermal stimulus modalities. Children with JIA were hyper-
sensitive (lower pain thresholds) to pressure and thermal
pain compared to healthy controls.
Table 2 Absolute QST values at joint test-site in children with JIA according to joint inflammation status
a
Upper extremity Lower extremity
QST parameter Active joint (n= 11) Inactive joint (n=20) p-value
b Active joint (n=12) Inactive joint (n= 17) p-value
b
Innocuous stimulus
MDT (g) 0.05 (0.04-0.16) 0.08 (0.04-0.40) 0.11 0.28 (0.07-0.43) 0.40 (0.18-0.53) 0.26
VDT (μm/sec) 0.69 (0.54-0.84) 0.64 (0.57-0.81) 0.87 2.01 (1.74-3.61) 4.25 (2.14-5.35) 0.21
CDT (°C) 30.1 (28.2-30.7) 30.4 (29.0-30.9) 0.83 28.5 (26.2-29.1) 27.8 (24.5-29.4) 0.78
WDT (°C) 34.7 (34.3-38.5) 34.5 (33.9-35.9) 0.69 37.0 (36.1-39.2) 36.9 (35.7-38.5) 0.87
Noxious stimulus
MPT (g) 0.40 (0.06-1.70) 0.50 (0.40-3.50) 0.17 0.60 (0.34-1.00) 1.00 (0.40-1.60) 0.40
PPT (N) 7.47 (5.37-15.0) 10.4 (6.50-16.3) 0.27 12.6 (10.3-21.2) 14.9 (7.78-21.6) 0.85
CPT (°C) 29.4 (21.6-30.3) 25.6 (20.0-28.6) 0.06 24.0 (16.9-26.9) 24.6 (20.4-26.0) 0.87
HPT (°C) 36.7 (35.9-42.9) 38.2 (36.3-40.8) 0.62 43.9 (40.7-45.0) 41.3 (39.1-43.2) 0.19
CDT- Cold Detection Threshold, CPT, Cold Pain Threshold; HPT, Heat Pain Threshold; IQR- Inter-Quartile Range; MDT- Mechanical Detection Threshold;
MPT- Mechanical Pain Threshold; PPT, Pressure Detection Threshold; VDT- Vibration Detection Threshold; WDT- Warm Detection Threshold.
a.All values given as median (IQR) unless otherwise stated. Eight children with JIA were taking daily NSAIDs at the time of study. Two had active arthritis and were
evaluated for QST at the finger or knee; 6 were in clinical remission and were evaluated at the finger (n = 3), knee (n= 1) or ankle (n = 1).
b.p-values indicate
differences in sensory threshold between Active and Inactive joints using Mann–Whitney U-test.
Table 3 Absolute QST values at control site (thenar eminence) in children with JIA according to joint inflammation status
a
Upper extremity Lower extremity
QST parameter Active joint (n= 11) Inactive joint (n= 20) Active joint (n= 12) Inactive joint (n= 17) p-value
b
Innocuous stimulus
MDT (g) 0.04 (0.03-0.08) 0.04 (0.02-0.05) 0.04 (0.02-0.05) 0.05 (0.04-0.09) 0.08
VDT (μm/sec) 0.58 (0.42-1.20) 0.69 (0.59-1.03) 0.64 (0.50-0.81) 0.80 (0.63-0.91) 0.35
CDT (°C) 30.4 (29.5-30.8) 30.2 (29.7-30.7) 29.9 (29.2-30.5) 30.2 (27.5-30.6) 0.60
WDT (°C) 34.8 (33.8-36.0) 34.6 (34.2-35.2) 34.8 (34.2-36.5) 34.9 (33.7-35.5) 0.95
Noxious stimulus
MPT (g) 0.8 (0.4-1.4) 1.0 (0.4-2.5) 1.2 (0.8-3.7) 1.3 (0.6-4.5) 0.46
PPT (N) 6.1 (4.5-15.0) 10.7 (8.4-16.3) 11.3 (5.8-16.9) 9.7 (7.4-15.2) 0.58
CPT (°C) 29.1 (25.0-30.6) 25.7 (14.3-29.0) 21.1 (15.5-25.4) 26.6 (22.0-28.9) 0.03
c
HPT (°C) 37.2 (35.7-40.3) 37.8 (35.4-43.0) 41.1 (38.6-45.5) 37.5 (35.9-43.2) 0.17
CDT- Cold Detection Threshold, CPT, Cold Pain Threshold; HPT, Heat Pain Threshold; IQR- Inter-Quartile Range; MDT- Mechanical Detection Threshold;
MPT- Mechanical Pain Threshold; PPT, Pressure Detection Threshold; VDT- Vibration Detection Threshold; WDT- Warm Detection Threshold.
a.All values given as median (IQR) unless otherwise stated. Eight children with JIA were taking daily NSAIDs at the time of study.
b.p-values indicate differences in
sensory threshold between all four groups using Kruskal-Wallis testing. Boldface highlights significant differences.
c.Significant differences for CPT found between
JIA patients with active arthritis in the upper extremity vs lower extremity after Dunn’s correction for multiple comparisons; no other comparisons were different.
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lation and reported pain at lower median forces of 10.3 N
(IQR: 6.3-15.5) compared to EU controls, 45.8 N (IQR:
35.6-55.6; p< 0.001). The differences between the groups
were equivalent to at least 30 N, or 3 kg.
For thermal pain threshold, children with JIA were
more sensitive to cold pain and heat pain compared to
healthy controls. Children with JIA had lower sensory
thresholds for cold pain (as shown by a smaller change in
cold temperature from baseline), the median temperature
change was 6.3°C (IQR: 3.1-14.7); US controls were 17.9°C
(IQR: 10.6-26.9), and EU control were 10.4°C (IQR
6.8-18.6); (vs. US, p < 0.001; vs. EU, p < 0.01). Heat
pain thresholds were evaluated in the children with JIA
and compared to the same healthy control subjects, the
variability within each group was smaller than for CPT.
Children with JIA perceived heat pain at a median
temperature increase of 6.2°C (IQR: 4.0-10.3), US control
was 10.3°C (IQR: 7.6-26.9; p<0.001), and EU control was
8.6°C (IQR: 6.1-11.9; p<0.05). Absolute median (IQR)
and p-values are given in the Additional file 3: Table B.
Sensory detection threshold
Figure 2 illustrates sensory detection thresholds to
innocuous vibration and thermal stimuli at the thenar
eminence. JIA patients were more sensitive to mechanical
stimuli (0.04 g, IQR 0.03-0.07) compared to healthy
controls (EU 0.23 g, IQR: 0.18-0.33; p< 0.001).
In contrast, children with JIA had vibration detection
thresholds of 0.68 μm/sec (IQR 0.53-0.90) that were
significantly lower (hyposensitive) compared to healthy
controls (US: 0.2 μm/sec, IQR: 0.2-0.25; p<0.001). Simi-
larly, for CDT and WDT, a greater temperature change
was required for JIA patients to perceive temperature
compared to healthy controls from both the US and EU
(see Additional file 3: Table B).
The JIA cohort contained a higher proportion of girls
(72%) compared to both healthy control data sets
(50% in each). Sensitivity analyses, by excluding boys in all
groups and examining QST parameters for children with
JIA and healthy controls, showed no significant differences
for all QST measures (data not shown).
Discussion
We examined local and systemic inflammatory markers,
current pain score, functional disability, psychological mea-
sures, and QST in children withJ I A .A sag r o u p ,t h e yh a d
mild pain scores, low disability inventories, and normal
ranges for psychological measures. In addition, their local
and systemic markers of inflammation or disease activity
were mild. Despite these factors, children with JIA exhibited
pain hypersensitivity in areas outside of the affected joint, in
response to pressure, thermal cold and heat pain modalities
when compared to healthy controls. Additionally, we ob-
served that children with JIA had substantially lower sensi-
tivity (increased thresholds) to innocuous vibratory, thermal
cool and warmth modalities when compared to healthy con-
trols. Widespread pain hypersensitivity in children with JIA
suggests that potentiated nociceptive processing can occur
with minimal overt evidence for ongoing inflammation.
Early sensory studies demonstrate that children with
chronic arthritis and inflammation exhibit hypersensitivity
to pressure pain compared to healthy controls when local
pressure was applied to joint capsules at locations such as
the wrists, elbows, knees, ankles and/or soft paraspinal
tissues [5-7,25]. Our data support these findings, showing
generalized changes in sensitivity in children with JIA when
compared to healthy controls. We also show that pain
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Figure 1 Noxious thresholds for pressure, cold and heat pain at thenar eminence. Pressure, and temperature change from baseline, where
the sensation of (A) pressure, (B) cold and (C) heat pain were perceived are plotted for JIA patients (JIA, n=58), and controls (EU, n= 151; US,
n= 92). JIA patients were hypersensitive to all modalities. MPT is not included because we do not have comparison values from healthy controls.
Individuals represented by single dots, Box and Whisker plot illustrates median, IQR and range. *p< 0.05; **p<0.01; ***p<0.001.
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http://www.ped-rheum.com/content/12/1/39perception and sensory threshold in all mechanical and
thermal stimulus modalities did not markedly differ be-
tween JIA groups with “Active” and “Inactive” joint
inflammation. This result was contrary to our expectations
that active joints with clinical signs of inflammation would
be more sensitive than joints without signs of inflammation.
Indeed, pressure pain hypersensitivity has been shown to be
greater in children with active inflammation than in those
with arthritis but no detectable inflammation [5]. However,
other work such as that by Leegaurd et al. evaluated pres-
sure pain in children with JIA at 17 body sites, even in areas
unaffected by arthritis, and reported that pressure pain
threshold was not associated with disease severity [7].
Previous epidemiologic studies and case series on pain
prevalence and disease severity in JIA have varied
considerably in their reported degrees of pain intensity
and pain-related disability. Pain is a common experience
in children with JIA, with intensity often reported in the
mild to moderate range [26]. Previous studies show that
higher pain scores among children with JIA correlated
with lower pain pressure thresholds and pain tolerance
[5,27]. However, disease duration, disease activity and
pressure pain threshold have also been shown to be inde-
pendent factors in JIA [7,27]. In our study, sensory thresh-
old was similar in active and inactive joints. Also, since
our sample were characterized by low markers of disease
activity, it is plausible that subclinical signs of inflam-
mation may have been present in some of the JIA pa-
tients allocated to the “Inactive” joint group. These
differences may reflect different patient selection, secular
AB
CD
Figure 2 Mechanical, vibration, cool and warmth detection thresholds at thenar eminence. (A) Mechanical, (B) vibration, and (C) cool and
(D) warm (temperature change from baseline), detection thresholds are plotted for JIA patients (JIA, MDT, n= 60, VDT, n= 56, CDT/WDT, n=58),
and controls (EU, n=151; US, n=92). JIA patients exhibited altered sensation to all innocuous modalities. Individuals represented by single dot,
Box and Whisker plot illustrates median, IQR and range. **p< 0.01; ***p<0.001.
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http://www.ped-rheum.com/content/12/1/39trends over time due to improvements in disease manage-
ment, or other factors.
In the absence of high pain report, functional disability
and psychological impairment, children with JIA show
generalized alteration in pain threshold and sensory
perception of all stimulus modalities compared to healthy
controls. We followed the guidelines and QST protocol
for children according to standardized procedures to
reduce variation QST measures. Healthy control data were
collected from two different countries and conducted by a
range of experimenters and languages, and included the
similar age range. There is the potential for subtle changes
in QST data acquisition that may influence the variability
of the data. We note that thermal testing in the JIA
patients was conducted with a smaller thermode test area
(1.6 × 1.6 cm) compared to the healthy controls (3 × 3 cm).
The choice of probe was based on contact area required
around relatively small joints. A pilot study performed in 8
healthy volunteers showed no trend in the direction of sen-
sitivity (increased or decreased) when comparing the two
probe sizes (data not shown). Indeed, one would pre-
dict that under normal conditions as stimulus area de-
creases, overall perceived cool or warmth intensity is
likely to be lower (less sensitive) because the density of ac-
tivated afferent fibers is smaller, which was contrary to our
results. Additionally, a small number of children (n=8; 2
with active arthritis, and 6 in clinical remission) were pre-
s c r i b e dd a i l yN S A I D sa tt h et i m eo fs t u d yt h a th a st h ep o -
tential to dampen experimental pain perception [28]. In
view of these factors, we still observe substantially marked
pain hypersensitivity for pressure, heat and cold modalities,
as well as sensory detection hyposensitivity for vibration,
thermal cool and warm modalities for the entire sample of
JIA patients compared to both healthy control groups.
Persistent sensory alterations in pediatric chronic pain
conditions
Our findings extend the current literature and suggest that
children with JIA exhibit heightened pain sensitivity to mul-
tiple modalities compared to healthy controls. These results
are consistent with other childhood chronic pain conditions
investigating pain threshold, including complex regional
pain syndrome [23], sickle cell disease [25], fibromyalgia
[29], recurrent abdominal pain [30], tension-type headache
and migraine [31,32]. In addition to pain hypersensitivity,
we also observed increased sensory detection thresholds
(widespread hyposensitivity) to innocuous vibration and
thermal detection modalities. These results are novel in this
population and consistent with other studies examining re-
current pain in childhood. Work by McGrath’s group re-
cently showed that children with sickle cell disease were
less sensitive to thermal warm and cool temperatures, but
hypersensitive to cold pain when compared with controls
[30]. Children exposed to tissue (burn) injury during
infancy are shown to have mechanical pain hypersensitivity
and elevated mechanical detection thresholds (hyposensi-
tivity) when tested at a non-burn site and compared to
healthy controls [33]. Children who underwent cardiac
surgery in infancy also exhibit mechanical hyposensitivity
in a non-injured thenar eminence site compared to age-
matched control [34]. The underlying mechanisms remain
unclear but may be due to the fact that different afferent
fibers types may be more susceptible to experience-
dependent stress, pain exposure, joint damage, and an-
algesic and anti-inflammatory treatments [3].
The generalized enhanced sensitivity to mechanical
and thermal stimuli modalities in joint areas, and those
outside of the area of local inflammation, in children
with JIA may reflect global changes in peripheral and
central pain processing. Persistent inflammation at
critical stages in early life, as seen in children with JIA,
may modulate key sites involved in pain processing. At
the periphery, enhanced release of pro-inflammatory
cytokines, prostaglandins, peptides and growth factors
from the inflamed tissue surrounding the joint that
sensitizes nociceptor terminals [35]. Even in the absence
of persistent inflammation, exposure to a mild physical
insult such as visceral inflammation or repeated visceral
distension which causes no lasting tissue damage, or a
stressful environment in young rats leads to prolonged
hypersensitivity of afferent nociceptive fibers [36,37]. In
addition, central sensitization of sensory circuitry, as
characterized by increased neural excitability, strength-
ened excitatory input and decreased inhibitory activity is
thought to be a key component in the transition from
acute to chronic pain, and is hypothesized to play a role
in pain in adult rheumatologic disease [38]. Finally,
descending control from the brainstem, and functional
connectivity changes at higher brain centers involved in
pain processing at a critical time of synaptic plasticity
may be implicated [3]. However, the role of central
sensitization in these patients remains speculative, since
overall pain reports were low.
Limitations
QST was performed according to standardized instructions
for children to ensure inter-experimental reliability.
Nevertheless, QST measures can be influenced by a range
of factors including experimental anxiety, attention,
learning, coping style, and environmental conditions.
Sensory thresholds in both normal subjects and in JIA
patients vary according to sites tested. We evaluated joints
in the JIA patients based on the locations of greatest past
or present inflammation for each individual patient.
Further QST profiling studies are needed to compare
changes in sensory function at site-specific locations in
larger samples for each involved joint, both in children
with JIA patients and in healthy controls. Two historical
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larger sample sizes and a similar age range were used
in this study for reference comparisons. While subtle
changes in testing protocols and data capture
methods may exist, it is remarkable how the changes
in sensitivity seen in children with JIA are consistent
when compared to both healthy control groups.
Conclusions
We have demonstrated that while the majority of children
with JIA in this study reported mild pain and mild impair-
ment or disability, as a group, they showed measurable
abnormalities in sensory processing compared to healthy
controls. The changes in the sensory profile were detected
even when little evident local or systemic inflammation was
seen clinically. These results may be consistent with a
pattern of central sensitization and highlight the necessity
to improve the management of JIA with a multidisciplinary
treatment approach. A small subset of JIA patients seen in
our Rheumatology and Pain Clinics have greater degrees of
pain and disability than most those in the current study. In
some cases, pain and disability is present with compara-
tively mild indices of local or systemic inflammation. For
these patients, it is plausible that treatment should
emphasize not just suppression of inflammation, but also
more broad-based approaches to management of pain. For
example, it may be worth considering pharmacologic
approaches to mitigate pain hypersensitivity (e.g. anticon-
vulsants, antidepressants and other medications used for
neuropathic pain). In addition, cognitive-behavioral therapy,
lifestyle interventions, physical therapy approaches, includ-
ing active exercise, and other rehabilitative approaches
that activate intrinsic pain inhibitory modulation. Future
research may further analyze mechanisms underlying pain
hypersensitivity in JIA, which will in turn guide pharmaco-
logic and non-pharmacologic interventions to prevent or
reverse these processes.
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